Abstract
Alzheimers disease (AD) is one of the most discussed diseases of present time. Because of the aging of our population it is high threat for future. Due to this, new drugs combating AD are still developed. In this study, twelve bisquaternary isoquinolinium derivatives differing in the linker between two heteroarenium rings were synthesized and tested for their potency to inhibit brain cholinesterases. According to the obtained in vitro results, the anticholinesterase activity grew up with the length of the connection chain. Possible binding to the enzyme cavity was described using software Autodock. Moreover, LogP and molecular volume of prepared compounds were predicted. As resulted, the highest probability of synthesized compounds to penetrate blood-brain barrier could be expected for the compound with linker having eight methylenes.
Keywords: Quinolinium, Quaternary compounds, Inhibitor, Cholinesterase, Alzheimer's disease, Anticholinergic
Letters in Drug Design & Discovery
Title: New Bisquaternary Isoquinolinium Inhibitors of Brain Cholinesterases - Synthesis and Anticholinesterase Activity
Volume: 7 Issue: 1
Author(s): Jiri Binder, Martin Paar, Daniel Jun, Miroslav Pohanka, Martina Hrabinova, Veronika Opletalova and Kamil Kuca
Affiliation:
Keywords: Quinolinium, Quaternary compounds, Inhibitor, Cholinesterase, Alzheimer's disease, Anticholinergic
Abstract: Alzheimers disease (AD) is one of the most discussed diseases of present time. Because of the aging of our population it is high threat for future. Due to this, new drugs combating AD are still developed. In this study, twelve bisquaternary isoquinolinium derivatives differing in the linker between two heteroarenium rings were synthesized and tested for their potency to inhibit brain cholinesterases. According to the obtained in vitro results, the anticholinesterase activity grew up with the length of the connection chain. Possible binding to the enzyme cavity was described using software Autodock. Moreover, LogP and molecular volume of prepared compounds were predicted. As resulted, the highest probability of synthesized compounds to penetrate blood-brain barrier could be expected for the compound with linker having eight methylenes.
Export Options
About this article
Cite this article as:
Binder Jiri, Paar Martin, Jun Daniel, Pohanka Miroslav, Hrabinova Martina, Opletalova Veronika and Kuca Kamil, New Bisquaternary Isoquinolinium Inhibitors of Brain Cholinesterases - Synthesis and Anticholinesterase Activity, Letters in Drug Design & Discovery 2010; 7 (1) . https://dx.doi.org/10.2174/1570180811007010001
DOI https://dx.doi.org/10.2174/1570180811007010001 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Self-defining Memories and their Contribution to the Sense of Self in Alzheimer’s Disease
Current Alzheimer Research Midlife Modifiable Risk Factors for Dementia: A Systematic Review and Meta-analysis of 34 Prospective Cohort Studies
Current Alzheimer Research Brain Molecules and Appetite: The Case of Oleoylethanolamide
Central Nervous System Agents in Medicinal Chemistry Parallel Solution-Phase Synthesis of a 2-Aminothiazole Library Including Fully Automated Work-Up
Combinatorial Chemistry & High Throughput Screening Biological Signatures of Alzheimer’s Disease
Current Topics in Medicinal Chemistry Emerging Synergisms Between Drugs and Physiologically-Patterned Weak Magnetic Fields: Implications for Neuropharmacology and the Human Population in the Twenty-First Century
Current Neuropharmacology The TWEAK-Fn14 System: Breaking the Silence of Cytokine-Induced Skeletal Muscle Wasting
Current Molecular Medicine Is there a Possible Single Mediator in Modulating Neuroendocrine–thymus Interaction in Ageing?
Current Aging Science Circulating Biochemical Markers of Brain Damage in Infants Complicated by Ischemia Reperfusion Injury
Cardiovascular & Hematological Agents in Medicinal Chemistry The Role of Focal Adhesion Kinase in Lung Cancer
Anti-Cancer Agents in Medicinal Chemistry Th17 Cells in Airway Diseases
Current Molecular Medicine Potential Beneficial Effects of Marine Peptide on Human Neuron Health
Current Protein & Peptide Science Early Palliative Care in Advanced Oncologic and Non-Oncologic Chronic Diseases: A Systematic Review of Literature
Reviews on Recent Clinical Trials Isatoic Anhydride: A Fascinating and Basic Molecule for the Synthesis of Substituted Quinazolinones and Benzo di/triazepines
Current Organic Chemistry Smoking and Endothelial Progenitor Cells: A Revision of Literature
Current Pharmaceutical Design Characterisation of Mitochondrial DNA Deletions by Long-PCR in Central Nervous System Regions of Young, Middle- and Old-aged Rats
Current Aging Science Role of Oxidative Stress and Metal Toxicity in the Progression of Alzheimer’s Disease
Current Neuropharmacology Polymeric Biomaterial and Lipid Based Nanoparticles for Oral Drug Delivery
Current Medicinal Chemistry The Urokinase Receptor in the Central Nervous System
CNS & Neurological Disorders - Drug Targets Low Estimated Glomerular Filtration Rate is Associated with High Recurrence Rate and Poor Prognosis of Hemorrhage Stroke
Current Neurovascular Research